Table 5 Potential differences between type 2 diabetes and CHF with regards to uncertainty, and how they might influence CAS characteristic effectiveness
CAS characteristic | type 2 diabetes | CHF |
|---|---|---|
Learning | Treatment is nuanced and complex, making efforts to improve outcomes through learning more difficult. | Less uncertainty in treatment guidelines allows more prescriptive, algorithmic approaches to management that may be more easily learned. |
Interconnections | Greater degree of uncertainty in terms of symptoms and management, leading to greater reliance on interconnections to manage disease. | Lesser degree of uncertainty in terms of symptoms and management may lead interventions focused on interconnections less effective. |
Self-organization | Greater uncertainty in management and symptoms of exacerbation may make efforts to self-organize more difficult. | Less uncertainty regarding management and symptoms of exacerbation may make efforts to self-organize more effective. |
Co-evolution | Course and symptoms evolve over time in unique trajectory. | Course and symptoms evolve over time in unique trajectory. |